This legislation directs the Secretary of Veterans Affairs to conduct a comprehensive review of opioid overdose deaths among veterans who received VA care within five years prior to their death. This initiative is prompted by congressional findings indicating a significant rise in veteran opioid overdose fatalities, particularly from heroin and synthetic opioids, and a substantial increase in overdose rates despite a decline in prescription opioid receipt before death. The detailed review, to be completed within 18 months, will analyze the total number of deaths, demographics, and a comprehensive list of medications prescribed to and found in deceased veterans, including those with black box warnings . It will also examine medical diagnoses leading to prescriptions, instances of concurrent multiple VA-prescribed medications, and the percentage of veterans with combat experience or trauma. Additionally, the review requires identifying VA facilities with high prescription and drug abuse treatment rates, describing VA prescribing policies, and detailing efforts to manage unused prescription opioids. Ultimately, the Secretary must identify patterns from the review and provide recommendations to enhance veteran safety and reduce opioid overdose rates, specifically addressing veterans who had not received an opioid prescription in the three months prior to their overdose. The findings will be reported to Congress, made publicly available, and presented in a briefing.